{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:07:57Z","timestamp":1793506077662,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T00:00:00Z","timestamp":1683763200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["F31 HL162483-01A1"],"award-info":[{"award-number":["F31 HL162483-01A1"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R00HL151965"],"award-info":[{"award-number":["R00HL151965"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01GM080403"],"award-info":[{"award-number":["R01GM080403"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01GM129261"],"award-info":[{"award-number":["R01GM129261"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM133552"],"award-info":[{"award-number":["R35GM133552"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["OLIVER22A0-KB"],"award-info":[{"award-number":["OLIVER22A0-KB"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["SCHLEB18I0"],"award-info":[{"award-number":["SCHLEB18I0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["SCHLEB19I0"],"award-info":[{"award-number":["SCHLEB19I0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006733","name":"Indiana University","doi-asserted-by":"publisher","award":["T32 GM109825"],"award-info":[{"award-number":["T32 GM109825"]}],"id":[{"id":"10.13039\/100006733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Chemical Biology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.chembiol.2023.05.001","type":"journal-article","created":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T14:29:27Z","timestamp":1685370567000},"page":"632-642.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["General trends in the effects of VX-661 and VX-445 on the plasma membrane expression of clinical CFTR variants"],"prefix":"10.1016","volume":"30","author":[{"given":"Andrew G.","family":"McKee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli F.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesley D.","family":"Penn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles P.","family":"Kuntz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Noguera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Chamness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis J.","family":"Roushar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Meiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn E.","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Plate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0955-7633","authenticated-orcid":false,"given":"Jonathan P.","family":"Schlebach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chembiol.2023.05.001_bib1","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0092-8674(90)90148-8","article-title":"Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis","volume":"63","author":"Cheng","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2023.05.001_bib2","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1091\/mbc.e14-04-0935","article-title":"From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations","volume":"27","author":"Veit","year":"2016","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.chembiol.2023.05.001_bib3","doi-asserted-by":"crossref","first-page":"18843","DOI":"10.1073\/pnas.1105787108","article-title":"Correction of the F508del-CFTR protein processing defect in\u00a0vitro by the investigational drug VX-809","volume":"108","author":"Van Goor","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2023.05.001_bib4","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1172\/JCI24898","article-title":"Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening","volume":"115","author":"Pedemonte","year":"2005","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.chembiol.2023.05.001_bib5","doi-asserted-by":"crossref","first-page":"a009761","DOI":"10.1101\/cshperspect.a009761","article-title":"Cystic fibrosis transmembrane regulator correctors and potentiators","volume":"3","author":"Rowe","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.chembiol.2023.05.001_bib6","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nchembio.1253","article-title":"Mechanism-based corrector combination restores \u0394F508-CFTR folding and function","volume":"9","author":"Okiyoneda","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.chembiol.2023.05.001_bib7","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1091\/mbc.e13-05-0240","article-title":"VX-809 corrects folding defects in cystic fibrosis transmembrane conductance regulator protein through action on membrane-spanning domain 1","volume":"24","author":"Ren","year":"2013","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.chembiol.2023.05.001_bib8","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cell.2021.12.009","article-title":"Mechanism of CFTR correction by type I folding correctors","volume":"185","author":"Fiedorczuk","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.chembiol.2023.05.001_bib9","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1056\/NEJMoa1709846","article-title":"Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del","volume":"377","author":"Taylor-Cousar","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.chembiol.2023.05.001_bib10","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.chembiol.2023.05.001_bib11","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1126\/science.aaw7611","article-title":"Structural identification of a hotspot on CFTR for potentiation","volume":"364","author":"Liu","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2023.05.001_bib12","doi-asserted-by":"crossref","first-page":"e139983","DOI":"10.1172\/jci.insight.139983","article-title":"Allosteric folding correction of F508del and rare CFTR mutants by elexacaftor-tezacaftor-ivacaftor (Trikafta) combination","volume":"5","author":"Veit","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.chembiol.2023.05.001_bib13","doi-asserted-by":"crossref","first-page":"19810","DOI":"10.1038\/s41598-021-99184-1","article-title":"Elexacaftor is a CFTR potentiator and acts synergistically with ivacaftor during acute and chronic treatment","volume":"11","author":"Shaughnessy","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.chembiol.2023.05.001_bib14","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1126\/science.ade2216","article-title":"Molecular structures reveal synergistic rescue of \u0394F508 CFTR by Trikafta modulators","volume":"378","author":"Fiedorczuk","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.chembiol.2023.05.001_bib15","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3390\/jpm11070643","article-title":"Precision medicine approach to optimize modulator therapy for rare CFTR folding mutants","volume":"11","author":"Veit","year":"2021","journal-title":"J.\u00a0Personalized Med."},{"key":"10.1016\/j.chembiol.2023.05.001_bib16","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1093\/nar\/gkx183","article-title":"A platform for functional assessment of large variant libraries in mammalian cells","volume":"45","author":"Matreyek","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.chembiol.2023.05.001_bib17","doi-asserted-by":"crossref","first-page":"eaay7505","DOI":"10.1126\/sciadv.aay7505","article-title":"Probing biophysical sequence constraints within the transmembrane domains of rhodopsin by deep mutational scanning","volume":"6","author":"Penn","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.chembiol.2023.05.001_bib18","doi-asserted-by":"crossref","first-page":"102266","DOI":"10.1016\/j.jbc.2022.102266","article-title":"Molecular basis for variations in the sensitivity of pathogenic rhodopsin variants to 9-cis-Retinal","volume":"298","author":"Roushar","year":"2022","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2023.05.001_bib19","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ng.2745","article-title":"Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene","volume":"45","author":"Sosnay","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.chembiol.2023.05.001_bib20","doi-asserted-by":"crossref","first-page":"21873","DOI":"10.1074\/jbc.274.31.21873","article-title":"C-terminal truncations destabilize the cystic fibrosis transmembrane conductance regulator without impairing its biogenesis. A novel class of mutation","volume":"274","author":"Haardt","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2023.05.001_bib21","doi-asserted-by":"crossref","first-page":"6352","DOI":"10.1021\/bi100807h","article-title":"The V510D suppressor mutation stabilizes DeltaF508-CFTR at the cell surface","volume":"49","author":"Loo","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.chembiol.2023.05.001_bib22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fphar.2012.00201","article-title":"Mechanisms of CFTR folding at the endoplasmic reticulum","volume":"3","author":"Kim","year":"2012","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.chembiol.2023.05.001_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nsmb882","article-title":"The DeltaF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR","volume":"12","author":"Du","year":"2005","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.chembiol.2023.05.001_bib24","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1091\/mbc.e08-09-0950","article-title":"Cooperative assembly and misfolding of CFTR domains in\u00a0vivo","volume":"20","author":"Du","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.chembiol.2023.05.001_bib25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00018-016-2387-7","article-title":"From the endoplasmic reticulum to the plasma membrane: mechanisms of CFTR folding and trafficking","volume":"74","author":"Farinha","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.chembiol.2023.05.001_bib26","doi-asserted-by":"crossref","first-page":"ar62","DOI":"10.1091\/mbc.E21-11-0578","article-title":"Distinct proteostasis states drive pharmacologic chaperone susceptibility for cystic fibrosis transmembrane conductance regulator misfolding mutants","volume":"33","author":"McDonald","year":"2022","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.chembiol.2023.05.001_bib27","doi-asserted-by":"crossref","first-page":"e86581","DOI":"10.1172\/jci.insight.86581","article-title":"Analysis of cystic fibrosis-associated P67L CFTR illustrates barriers to personalized therapeutics for orphan diseases","volume":"1","author":"Sabusap","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.chembiol.2023.05.001_bib28","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/biom12030471","article-title":"Structural Comparative Modeling of Multi-Domain F508del CFTR","volume":"12","author":"McDonald","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.chembiol.2023.05.001_bib29","doi-asserted-by":"crossref","first-page":"12757","DOI":"10.1073\/pnas.1815287115","article-title":"Molecular structure of the ATP-bound, phosphorylated human CFTR","volume":"115","author":"Zhang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2023.05.001_bib30","doi-asserted-by":"crossref","first-page":"e17219","DOI":"10.7554\/eLife.17219","article-title":"Automated structure refinement of macromolecular assemblies from cryo-EM maps using Rosetta","volume":"5","author":"Wang","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.chembiol.2023.05.001_bib31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/978-1-61779-465-0_10","article-title":"Rosetta Ligand docking with flexible XML protocols","volume":"819","author":"Lemmon","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.chembiol.2023.05.001_bib32","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.str.2013.08.005","article-title":"High-resolution comparative modeling with RosettaCM","volume":"21","author":"Song","year":"2013","journal-title":"Structure"},{"key":"10.1016\/j.chembiol.2023.05.001_bib33","doi-asserted-by":"crossref","first-page":"e121159","DOI":"10.1172\/jci.insight.121159","article-title":"Residual function of cystic fibrosis mutants predicts response to small molecule CFTR modulators","volume":"3","author":"Han","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.chembiol.2023.05.001_bib34","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nature15729","article-title":"\u0394F508 CFTR interactome remodelling promotes rescue of cystic fibrosis","volume":"528","author":"Pankow","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2023.05.001_bib35","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1016\/j.jmb.2018.06.017","article-title":"A proteomic variant approach (ProVarA) for personalized medicine of inherited and somatic disease","volume":"430","author":"Hutt","year":"2018","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.chembiol.2023.05.001_bib36","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1124\/jpet.102.048454","article-title":"Structure-activity relations of successful pharmacologic chaperones for rescue of naturally occurring and manufactured mutants of the gonadotropin-releasing hormone receptor","volume":"305","author":"Janovick","year":"2003","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.chembiol.2023.05.001_bib37","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1021\/acs.chemrev.8b00532","article-title":"Folding and misfolding of human membrane proteins in Health and disease: from single molecules to cellular proteostasis","volume":"119","author":"Marinko","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.chembiol.2023.05.001_bib38","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1021\/jacs.8b08243","article-title":"Contribution of cotranslational folding defects to membrane protein homeostasis","volume":"141","author":"Roushar","year":"2019","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.chembiol.2023.05.001_bib39","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0014-5793(01)02561-3","article-title":"Green fluorescent protein-based halide indicators with improved chloride and iodide affinities","volume":"499","author":"Galietta","year":"2001","journal-title":"FEBS Lett."},{"key":"10.1016\/j.chembiol.2023.05.001_bib40","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/nmeth.4029","article-title":"Plasmid-based one-pot saturation mutagenesis","volume":"13","author":"Wrenbeck","year":"2016","journal-title":"Nat. Methods"},{"key":"10.1016\/j.chembiol.2023.05.001_bib41","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1021\/acs.jcim.0c01140","article-title":"BCL::Conf: improved open-source knowledge-based conformation sampling using the crystallography open database","volume":"61","author":"Mendenhall","year":"2021","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.chembiol.2023.05.001_bib42","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/prot.20817","article-title":"Multipass membrane protein structure prediction using Rosetta","volume":"62","author":"Yarov-Yarovoy","year":"2006","journal-title":"Proteins"},{"key":"10.1016\/j.chembiol.2023.05.001_bib43","doi-asserted-by":"crossref","first-page":"15682","DOI":"10.1073\/pnas.0702515104","article-title":"Toward high-resolution prediction and design of transmembrane helical protein structures","volume":"104","author":"Barth","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2023.05.001_bib44","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1093\/bioinformatics\/btn221","article-title":"OCTOPUS: improving topology prediction by two-track ANN-based preference scores and an extended topological grammar","volume":"24","author":"Viklund","year":"2008","journal-title":"Bioinformatics"}],"container-title":["Cell Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945623001253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945623001253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T17:53:20Z","timestamp":1726682000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451945623001253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2451945623001253"],"URL":"https:\/\/doi.org\/10.1016\/j.chembiol.2023.05.001","relation":{},"ISSN":["2451-9456"],"issn-type":[{"value":"2451-9456","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"General trends in the effects of VX-661 and VX-445 on the plasma membrane expression of clinical CFTR variants","name":"articletitle","label":"Article Title"},{"value":"Cell Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chembiol.2023.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}